Ad is loading...
BMCIX
Price
$29.33
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
MENRX
Price
$10.15
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
Ad is loading...

BMCIX vs MENRX

Header iconBMCIX vs MENRX Comparison
Open Charts BMCIX vs MENRXBanner chart's image
BlackRock High Equity Income Instl
Price$29.33
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Madison Covered Call & Equity Income R6
Price$10.15
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
BMCIX vs MENRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BMCIX vs. MENRX commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMCIX is a Buy and MENRX is a Buy.

FUNDAMENTALS
Fundamentals
BMCIX has more cash in the bank: 1.98B vs. MENRX (245M). MENRX pays higher dividends than BMCIX: MENRX (7.54) vs BMCIX (6.50). BMCIX was incepted earlier than MENRX: BMCIX (27 years) vs MENRX (12 years). BMCIX is a more actively managed with annual turnover of: 126.00 vs. MENRX (102.00). MENRX has a lower initial minimum investment than BMCIX: MENRX (500000) vs BMCIX (2000000). BMCIX annual gain was more profitable for investors over the last year : 17.16 vs. MENRX (8.36). MENRX return over 5 years is better than : 61.66 vs. BMCIX (48.62).
BMCIXMENRXBMCIX / MENRX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence27 years12 years-
Gain YTD10.9345.382203%
Front LoadN/AN/A-
Min. Initial Investment2000000500000400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.98B245M807%
Annual Yield % from dividends6.507.5486%
Returns for 1 year17.168.36205%
Returns for 3 years21.5820.58105%
Returns for 5 years48.6261.6679%
Returns for 10 years-2.8069.12-4%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ODP26.630.77
+2.98%
ODP Corp (The)
FMC58.331.13
+1.98%
FMC Corp
ZVRA9.130.16
+1.78%
Zevra Therapeutics
IKNA1.730.03
+1.76%
Ikena Oncology
AVGO163.940.69
+0.42%
Broadcom Inc.